Texas Yale Capital Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,202
Closed -$273K 473
2021
Q2
$273K Buy
2,202
+200
+10% +$25.1K 0.02% 387
2021
Q1
$236K Buy
+2,002
New +$235K 0.01% 397
2015
Q1
Sell
-15,465
Closed -$1.12M 480
2014
Q4
$1.12M Buy
15,465
+305
+2% +$21.2K 0.1% 168
2014
Q3
$939K Buy
15,160
+9,530
+169% +$606K 0.09% 169
2014
Q2
$359K Hold
5,630
0.05% 295
2014
Q1
$346K Buy
5,630
+400
+8% +$23.3K 0.05% 286
2013
Q4
$300K Hold
5,230
0.05% 249
2013
Q3
$278K Buy
+5,230
New +$281K 0.05% 251

Other funds holding MDT

Texas Yale Capital Corp's MDT Position: Q3 2021 in Review

Texas Yale Capital Corp sold out of Medtronic (MDT) in Q3 2021, closing a stake of 2,202 shares — an estimated $273K sold.

Texas Yale Capital Corp first reported a position in MDT in Q3 2013 and held it in 8 quarters. The position peaked at $1.12M in Q4 2014. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Texas Yale Capital Corp reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • Texas Yale Capital Corp sold 2,202 Medtronic shares in Q3 2021, an estimated $273K.
  • Texas Yale Capital Corp first reported a position in Medtronic in Q3 2013 and held it in 8 quarters.
  • Texas Yale Capital Corp's Medtronic position peaked at $1.12M in Q4 2014.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Texas Yale Capital Corp's 13F filing for Q3 2021, filed 8 Nov 2021.